The patient with transient ischemic attacks--is this the time for a new therapeutic approach?

Abstract

Current and future improvements in treatment to prevent cerebral infarction among patients with transient ischemic attacks may reduce neurological morbidity but may not lead to a proportional improvement in life expectancy. Because the long-term primary cause of death in these patients is myocardial infarction, it is most likely that the most important way to prolong survival may be the vigorous investigation of their cardiac status and the treatment of their coronary artery disease, even if asymptomatic.